Drugs / BTC-Ag-T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07614061 | May 2026 → Dec 2028 expected | gallbladder cancer, hilar cholangiocarcinoma | Shanghai Zhongshan Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BTC-Ag-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07614061 ↗ |
| Modality | Cell therapy | “autologous experimental T-cell therapy” NCT07614061 ↗ |
| Route | Intravenous | “IV infusion.” NCT07614061 ↗ |